Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Legal & Regulatory

Panacea Biotec Legal & Regulatory

Panacea Biotec filed appeals against three tribunal awards and will challenge a fourth. The company believes the awards are challengeable and foresees no material financial impact.

Source

NSE filing, NSE: PANACEABIO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Panacea Biotec Ltd: key numbers

Share price
₹329.05
Market cap
₹2,015 Cr
Revenue (annual)
₹639.8 Cr
Net profit (annual)
₹-5.37 Cr
P/E (TTM)
-283.1×Sector 46.1×
Promoter holding
72.48%+0.00% QoQ
FII holding
2.75%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Panacea Biotec Ltd

All →

Other legal & regulatory announcements

All →